Highlights from ESMO 2024: How does it affect drug development going forward
Our expert oncologists and regulatory leaders delve into the key highlights from the recent European Society for Medical Oncology (ESMO) Congress. This session explores groundbreaking research, innovative treatment approaches, and pivotal clinical trial results presented at ESMO. Our speakers analyze how these developments may influence the strategies of other drug developers, potentially reshaping the landscape of oncology research and treatment.
Related Insights
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Embarking on the Next Era of Precision Medicine
May 11, 2021
Blog
Highlights from ASCO: Our experts weigh in
Jul 13, 2021
Article
New endpoints for early-stage cancer are gaining regulatory traction
Jan 28, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
What Do the Next 10 Years Hold for CRISPR?
Jul 27, 2022
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Podcast
Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Sep 19, 2022
Article
Q&A Project Optimus: What you need to know
Oct 11, 2022
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Related Insights
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Embarking on the Next Era of Precision Medicine
May 11, 2021
Blog
Highlights from ASCO: Our experts weigh in
Jul 13, 2021
Article
New endpoints for early-stage cancer are gaining regulatory traction
Jan 28, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
What Do the Next 10 Years Hold for CRISPR?
Jul 27, 2022
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Podcast
Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Sep 19, 2022
Article
Q&A Project Optimus: What you need to know
Oct 11, 2022
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023